- Home
- SLS vs CPSS Comparison
SLS vs CPSS Comparison
Compare SLS & CPSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- CPSS
- Stock Information
- Founded
- SLS 2012
- CPSS 1991
- Country
- SLS United States
- CPSS United States
- Employees
- SLS N/A
- CPSS N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- CPSS Finance: Consumer Services
- Sector
- SLS Health Care
- CPSS Finance
- Exchange
- SLS Nasdaq
- CPSS Nasdaq
- Market Cap
- SLS 169.6M
- CPSS 193.8M
- IPO Year
- SLS N/A
- CPSS 1992
- Fundamental
- Price
- SLS $1.54
- CPSS $9.85
- Analyst Decision
- SLS
- CPSS
- Analyst Count
- SLS 0
- CPSS 0
- Target Price
- SLS N/A
- CPSS N/A
- AVG Volume (30 Days)
- SLS 2.6M
- CPSS 16.5K
- Earning Date
- SLS 08-12-2025
- CPSS 07-29-2025
- Dividend Yield
- SLS N/A
- CPSS N/A
- EPS Growth
- SLS N/A
- CPSS N/A
- EPS
- SLS N/A
- CPSS 0.79
- Revenue
- SLS N/A
- CPSS $188,776,000.00
- Revenue This Year
- SLS N/A
- CPSS $146.82
- Revenue Next Year
- SLS N/A
- CPSS $18.24
- P/E Ratio
- SLS N/A
- CPSS $12.20
- Revenue Growth
- SLS N/A
- CPSS N/A
- 52 Week Low
- SLS $0.77
- CPSS $7.99
- 52 Week High
- SLS $2.12
- CPSS $12.73
- Technical
- Relative Strength Index (RSI)
- SLS 45.96
- CPSS 57.64
- Support Level
- SLS $1.47
- CPSS $9.45
- Resistance Level
- SLS $1.73
- CPSS $10.17
- Average True Range (ATR)
- SLS 0.11
- CPSS 0.24
- MACD
- SLS -0.02
- CPSS 0.01
- Stochastic Oscillator
- SLS 19.44
- CPSS 70.83
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About CPSS Consumer Portfolio Services Inc.
Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.